Immix Biopharma, Inc.

Ownership Transactions Reported by 12 Insiders

Symbol
IMMX on Nasdaq
Industry
Pharmaceutical Preparations
Location
11400 West Olympic Blvd., Suite 200, Los Angeles, CA

Insiders trading volume in the past year

Immix Biopharma, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Yekaterina Chudnovsky Director, 10%+ Owner $6.42M Jun 20, 2025
Vladimir Torchilin Scientific Co-Founder $4.23M Dec 20, 2021
Sean Senn Under 10% owner $4.21M Jul 14, 2022
Ilya Rachman CEO and Chairman, Director $2.3M +$10K +0.44% Sep 17, 2025
Carey Ng Director $2.07M Jun 20, 2025
Jason Hsu Director $1.87M +$104K +5.92% Jun 20, 2025
Nancy T. Chang Director $1.82M Sep 8, 2025
Gabriel Morris CFO, Director $620K +$10.2K +1.67% Sep 16, 2025
Helen C. Adams Director $346K Jun 20, 2025
Magda Marquet Director $131K Jun 20, 2025
Jane Buchan Director $44.5K Jun 20, 2025
Graham Ross CMO & Head of Clinical Dev. Dec 15, 2021

Recent Insider Transactions by Companies or Individuals for Immix Biopharma, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.